25 Oct 2018 --- Food & Beverage continued to drive positive results in Q3 across most segments and geographies, according to Danish biotech firm Novozymes, which reports 4 percent sales growth during the first nine months of 2018. The Danish biotech firm’s solutions for low-lactose dairy, trans fat reduction and acrylamide reduction continued their good momentum in the market, supported by increasing health awareness among consumers.